Dividend and Capital Repayment

CT UK High Income Trust PLC
21 November 2024
 

To:                   RNS

From:              CT UK High Income Trust PLC

Date:               21 November 2024

LEI:                  213800B7D5D7RVZZPV45

 

 

Dividend and Capital Repayment

 

The Board of CT UK High Income Trust PLC announces a third quarter dividend in respect of the financial year to 31 March 2025 of 1.35 pence per Ordinary share. This dividend will be paid on 7 February 2025 to Ordinary shareholders on the register on 3 January 2025, with an ex-dividend date of 2 January 2025. 

 

A third quarter capital repayment of 1.35 pence per B share will be paid on 7 February 2025 to B shareholders on the register on 3 January 2025, with an ex-dividend date of 2 January 2025. Capital repayments on B shares are paid at the same time and in an amount equal to each dividend paid on an Ordinary share.  

 

The normal pattern for the Company is to pay four quarterly interim distributions per financial year.

 

Including this distribution, the first three quarterly distributions will total 4.05 pence per share and in the absence of unforeseen circumstances, the Company currently intends that the aggregate distribution for the financial year to 31 March 2025 will be at least 5.62 pence per share (Financial year to 31 March 2024: 5.62 pence per share).

 

 

 

Enquiries:

David Moss, Portfolio Manager

Columbia Threadneedle Investment Business Limited

Tel: 0207 628 8000

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100